Image Of Sitagliptin Chemical Structure (Janumetxr 01)
Janumet Tablet, Film Coated, Extended Release
Product Images NDC 0006-0080
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Janumet (NDC 0006-0080). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image Of Metaformin Chemical Structure (Janumetxr 02)
Image Of Figure 1 (Janumetxr 03)
Image Of Figure 2 (Janumetxr 04)
Principal Display Panel (50 mg/500 mg Tablet Bottle Label)
The text provides information about a medication called Janumet XR, which is a tablet that contains sitagliptin and metformin HCl in extended-release form. The tablets are dispensed with a Medication Guide for each patient. The tablets contain 50mg of sitagliptin and 500mg of metformin hydrochloride extended-release. The dosage and storage information are also provided. Therefore, it can be said that the given text provides a brief description of Janumet XR, including its pharmacological information, dosage, and storage instructions with the storage temperature range.*
Principal Display Panel (50 mg/1,000 mg Tablet Bottle Label)
Janumet' XR is a medication in tablet form containing sitagliptin and metformin HCl (extended-release) in a 50 mg/1,000 mg strength. The National Drug Code (NDC) for this medication is 0006-0080-61 and the accompanying medication guide should be given to each patient receiving the medication. The tablets can be identified by the imprint of "6425" which is a combination of sitagliptin phosphate (50 mg) and metformin hydrochloride (1000 mg).*
Principal Display Panel (100 mg/1,000 mg Tablet Bottle Label)
Janumet'XR is a medication used in the treatment of type 2 diabetes. It is a combination of sitagliptin and metformin hydrochloride extended-release tablets. Each tablet contains 128.5mg of sitagliptin phosphate and 1000 mg of metformin hydrochloride. It should be taken once a day in the evening. The medication guide should be dispensed to each patient. The tablets come in a 30 count bottle and should be stored at a temperature between 15-30°C. The manufacturer of Janumet'XR is Merck & Co., Inc. Dosage information can be found on the label or by contacting a health professional.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
